AGA临床实践指南:胃轻瘫的管理
美国胃肠病协会(AGA)采用GRADE框架制定胃轻瘫管理指南,针对特发性或糖尿病相关胃轻瘫患者,就诊断性检查、药物治疗及手术/操作干预提出12条推荐,强调4小时胃排空检查、甲氧氯普胺或红霉素初始治疗,并指出多巴胺受体拮抗剂等药物及胃电刺激等不推荐常规使用。
要点
- 疑似胃轻瘫患者应使用4小时胃排空检查,不推荐2小时检查。
- 甲氧氯普胺或红霉素可作为胃轻瘫初始药物治疗。
- 不推荐多潘立酮、普芦卡必利、阿瑞匹坦、去甲替林、丁螺环酮和大麻二酚作为一线治疗。
核心结论
- 胃轻瘫诊断需使用4小时胃排空检查,甲氧氯普胺或红霉素适合初始药物治疗,其他治疗需医患共同决策,治疗需求仍远未满足。
研究设计与样本
- 美国胃肠病协会(AGA)采用GRADE框架,通过证据回顾和证据到决策框架制定指南,针对特发性或糖尿病相关胃轻瘫患者。
主要发现
- 指南共达成12条推荐,包括条件推荐反对2小时胃排空检查而支持4小时检查。
- 条件推荐使用甲氧氯普胺和红霉素治疗胃轻瘫。
- 条件推荐反对多潘立酮、普芦卡必利、阿瑞匹坦、去甲替林、丁螺环酮和大麻二酚作为一线治疗。
- 条件推荐反对常规初始使用胃经口内镜下幽门肌切开术或胃电刺激,保留用于药物治疗难治的特定患者。
- 对手术幽门肌切开术和手术幽门成形术未给出推荐,认为其使用存在知识缺口。
关键数值与推荐
- 反对2小时胃排空检查,支持4小时检查(条件推荐)。
- 推荐使用甲氧氯普胺和红霉素(条件推荐)。
- 反对多潘立酮、普芦卡必利、阿瑞匹坦、去甲替林、丁螺环酮和大麻二酚作为一线治疗(条件推荐)。
- 反对常规初始使用胃经口内镜下幽门肌切开术或胃电刺激(条件推荐)。
临床怎么用
- 疑似胃轻瘫患者应进行4小时胃排空检查以确保准确诊断。
- 初始药物治疗可选择甲氧氯普胺或红霉素。
- 其他药物及手术/操作治疗需与患者共同决策,并保留用于难治性患者。
局限性
- 手术幽门肌切开术和幽门成形术在胃轻瘫治疗中的使用存在知识缺口,未给出推荐。
- 胃轻瘫治疗仍存在相当大的未满足需求。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Gastroparesis is a complex gastric motility disorder characterized by nausea, vomiting, and other symptoms associated with a delay in gastric emptying in the absence of mechanical obstruction. Variations in diagnostic testing and limited effective treatments make caring for this patient population challenging. The American Gastroenterological Association developed this guideline to provide recommendations for ensuring an accurate diagnosis and identifying evidence-based, effective treatments among the available pharmacologic and procedural interventions for patients with idiopathic gastroparesis or gastroparesis related to diabetes. METHODS: The Grading of Recommendations Assessment, Development and Evaluation framework was used to assess evidence and develop this guideline. The Guideline Panel prioritized clinical questions and outcomes, conducted an evidence review, and used the Evidence to Decision Framework to develop recommendations. RESULTS: The Guideline Panel agreed on 12 recommendations. A conditional recommendation was issued against using 2-hour gastric emptying testing and in favor of 4-hour testing in patients with suspected gastroparesis. There are conditional recommendations for the use of metoclopramide and erythromycin in patients with gastroparesis. Conditional recommendations were issued against the use of domperidone, prucalopride, aprepitant, nortriptyline, buspirone, and cannabidiol as first-line therapies. In addition, conditional recommendations were issued against the routine initial use of gastric per-oral endoscopic pyloromyotomy or gastric electrical stimulation in patients with gastroparesis, reserving these treatments for select patients with symptoms refractory to medical therapies. No recommendation was given regarding the use of surgical pyloromyotomy and surgical pyloroplasty, which were identified as procedures with knowledge gaps in their use for treatment for gastroparesis. CONCLUSIONS: The diagnosis of gastroparesis requires the use of 4-hour gastric emptying tests. Metoclopramide or erythromycin is appropriate for initial pharmacologic treatment. Other treatment recommendations require shared patient-physician decision making. There are still considerable unmet needs in the treatment of gastroparesis.
引用
- Staller K, Parkman HP, Greer KB, et al. AGA Clinical Practice Guideline on Management of Gastroparesis. Gastroenterology. 2025. PMID: 40976635. doi:10.1053/j.gastro.2025.08.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。